SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-012503
Filing Date
2018-05-09
Accepted
2018-05-09 17:03:11
Documents
75
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cara-10q_20180331.htm 10-Q 1823552
2 EX-31.1 cara-ex311_110.htm EX-31.1 16103
3 EX-31.2 cara-ex312_108.htm EX-31.2 16044
4 EX-32.1 cara-ex321_109.htm EX-32.1 9367
  Complete submission text file 0001564590-18-012503.txt   7411739

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cara-20180331.xml EX-101.INS 1818177
6 XBRL TAXONOMY EXTENSION SCHEMA cara-20180331.xsd EX-101.SCH 48141
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cara-20180331_cal.xml EX-101.CAL 48281
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cara-20180331_def.xml EX-101.DEF 190432
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20180331_lab.xml EX-101.LAB 367433
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20180331_pre.xml EX-101.PRE 320484
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 18819259
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences